Pemphigus herpetiformis
See also: List of target antigens in pemphigus
Pemphigus herpetiformis (also known as "Acantholytic herpetiform dermatitis," "Herpetiform pemphigus," "Mixed bullous disease," and "Pemphigus controlled by sulfapyridine") is a cutaneous condition, a clinical variant of pemphigus that combines the clinical features of dermatitis herpetiformis with the immunopathologic features of pemphigus.[1]
Pathophysiology:
Pemphigus Herpetiformis is an IGg mediated autoantibodies that affect the epidermal layer of the skin. [2]
See also
References
- ↑ Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). Dermatology: 2-Volume Set. St. Louis: Mosby. ISBN 1-4160-2999-0.
- ↑ Sandhu, Neil. "Pemphigus Herpetiformis: Background, Pathophysiology, Epidemiology". Neil Sandhu, MD Dermatologist (Medical/Cosmetics) and Mohs Surgeon, Gulf Coast Dermatology.
This article is issued from Wikipedia - version of the Thursday, April 14, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.